Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population
Leukemia & Lymphoma | June 25, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-5
10.1080/10428194.2026.2687633
| PMID 42348303